C
8.43
-0.26 (-2.99%)
| Previous Close | 8.69 |
| Volume | 128,303 |
| Price / Sales | 159.29 |
| Price / Book | 31.26 |
| 52 Weeks Range |
| Profit Margin | -112.11% |
| Operating Margin (TTM) | -1,989.91% |
| Diluted EPS (TTM) | 5.33 |
| Quarterly Revenue Growth (YOY) | -81.20% |
| Total Debt/Equity (MRQ) | 1,948.27% |
| Current Ratio (MRQ) | 12.34 |
| Operating Cash Flow (TTM) | -30.86 M |
| Levered Free Cash Flow (TTM) | -47.63 M |
| Return on Assets (TTM) | -7.55% |
| Return on Equity (TTM) | -7,029.26% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Cartesian Therapeutics, Inc. | Mixed | Bearish |
AIStockmoo Score
-0.8
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | -0.83 |
|
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Value |
| % Held by Insiders | 59.96% |
| % Held by Institutions | 25.63% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Privium Fund Management B.V. | 30 Jun 2026 | 151,675 |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |